Company Filing History:
Years Active: 2025
Title: Elisa Magli: Innovator in Pharmaceutical Compositions
Introduction
Elisa Magli is a prominent inventor based in Portici, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for treating respiratory conditions. Her work has garnered attention for its potential impact on patient care and treatment efficacy.
Latest Patents
Elisa Magli holds a patent for "Budesonide 21-phosphate salts and pharmaceutical compositions containing the same." This invention relates to salts of budesonide 21-phosphate combined with β2 adrenergic agonists, such as formoterol. The pharmaceutical compositions developed from this invention are aimed at treating respiratory inflammatory pathologies, obstructive pathologies, and allergen-induced airway dysfunctions. Additionally, the patent outlines the process for preparing these salts, showcasing her innovative approach to pharmaceutical development.
Career Highlights
Elisa Magli is associated with Genetic S.p.A., a company known for its advancements in biotechnology and pharmaceuticals. Her role at the company has allowed her to focus on research and development, contributing to the creation of effective therapeutic solutions. With her expertise, she has been able to navigate the complexities of pharmaceutical innovation.
Collaborations
Elisa has collaborated with notable colleagues, including Giuseppe Caliendo and Giuseppe Cirino. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in their field.
Conclusion
Elisa Magli's contributions to pharmaceutical compositions demonstrate her commitment to improving healthcare outcomes. Her innovative work in developing budesonide 21-phosphate salts highlights the importance of research in addressing respiratory conditions. Through her career at Genetic S.p.A. and her collaborations, she continues to make a significant impact in the pharmaceutical industry.